Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-014978

Chief Financial Officer sold 13,000 shares at $211.37 ($2,747,810)

  • Chief Financial Officer acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2024-05-08 Option exercise 10b5-1 +12,000 $101.64 $1,219,680 105,056 D: show line 1 in the form
Sandercock Brett Chief Financial Officer 2024-05-08 Sale 10b5-1 −13,000 $211.37 $2,747,810 92,056 D: show line 2 in the form
Open-market sales · 13,000 sh · avg $211.37 · $2,747,810

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sandercock Brett Chief Financial Officer 2024-05-08 Option exercise · ResMed Common Stock Options 10b5-1 −12,000 10,883 D: show line 3 in the form
Loading xslF345X05/form4.xml…